Evogene Financials
| EVGN Stock | ILA 241.10 15.70 6.11% |
Evogene |
Understanding current and past Evogene Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Evogene's financial statements are interrelated, with each one affecting the others. For example, an increase in Evogene's assets may result in an increase in income on the income statement.
The data published in Evogene's official financial statements usually reflect Evogene's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Evogene. For example, before you start analyzing numbers published by Evogene accountants, it's critical to develop an understanding of what Evogene's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Evogene's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evogene's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Evogene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evogene. Please utilize our Beneish M Score to check the likelihood of Evogene's management manipulating its earnings.
Evogene Stock Summary
Evogene competes with Bezeq Israeli, and Compugen. Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 131 people.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011050551 |
| Business Address | 13 Gad Feinstein |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.evogene.com |
| Phone | (972) 8 946 6724 |
| Currency | ILA |
You should never invest in Evogene without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Evogene Stock, because this is throwing your money away. Analyzing the key information contained in Evogene's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Evogene Key Financial Ratios
Generally speaking, Evogene's financial ratios allow both analysts and investors to convert raw data from Evogene's financial statements into concise, actionable information that can be used to evaluate the performance of Evogene over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Evogene reports annually and quarterly.Evogene Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Evogene's current stock value. Our valuation model uses many indicators to compare Evogene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Evogene competition to find correlations between indicators driving Evogene's intrinsic value. More Info.Evogene is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Evogene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Evogene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Evogene's earnings, one of the primary drivers of an investment's value.Evogene Systematic Risk
Evogene's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Evogene volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Evogene correlated with the market. If Beta is less than 0 Evogene generally moves in the opposite direction as compared to the market. If Evogene Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Evogene is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Evogene is generally in the same direction as the market. If Beta > 1 Evogene moves generally in the same direction as, but more than the movement of the benchmark.
About Evogene Financials
What exactly are Evogene Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Evogene's income statement, its balance sheet, and the statement of cash flows. Potential Evogene investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Evogene investors may use each financial statement separately, they are all related. The changes in Evogene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evogene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Evogene Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Evogene is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Evogene has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Evogene's financials are consistent with your investment objective using the following steps:- Review Evogene's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Evogene's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Evogene's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Evogene's stock is overvalued or undervalued.
Evogene April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Evogene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Evogene. We use our internally-developed statistical techniques to arrive at the intrinsic value of Evogene based on widely used predictive technical indicators. In general, we focus on analyzing Evogene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Evogene's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (6.11) | |||
| Potential Upside | 5.94 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Evogene Stock analysis
When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |